Results 241 to 250 of about 276,656 (346)

Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care Assay

open access: yesJournal of Infectious Diseases, 2018
F. Lamoury   +19 more
semanticscholar   +1 more source

Higher afamin concentrations are associated with higher fatty liver indices: Population‐based KORA F4/FF4 study

open access: yesEuropean Journal of Clinical Investigation, EarlyView.
The present study aimed to investigate the associations between afamin and fatty liver and fibrosis indices and to study potential modifying effects of sex and glucose tolerance status on these associations in individuals from the population‐based KORA F4/FF4 cohort.
Corinna Niersmann   +14 more
wiley   +1 more source

Rising drug overdose deaths in chronic liver disease in the United States, 2015–2023 [PDF]

open access: yesClinical and Molecular Hepatology
Donghee Kim   +5 more
doaj   +1 more source

Production of interleukins 10 and 12 by peripheral blood mononuclear cells (PBMC) in chronic hepatitis C virus (HCV) infection

open access: green, 1997
Shinichi Kakumu   +5 more
openalex   +2 more sources

Imbalance of IL-1β and IL-1 receptor antagonist mRNA in liver tissue from hepatitis C virus (HCV)-related chronic hepatitis [PDF]

open access: bronze, 1999
Laura Gramantieri   +7 more
openalex   +1 more source

The UK Infected Blood Inquiry: A Personal Reflection

open access: yesHaemophilia, EarlyView.
ABSTRACT The UK Infected Blood Inquiry (IBI) considered the transfusion transmitted infections hepatitis B and C, HIV, and vCJD. The inquiry lasted 6 years during 2018 to 2024 and reported to the UK parliament on 20 May, 2024. It concluded that at least 3000 people died because of the recklessness and obstinacy of officialdom and it has been reported ...
Christine A. Lee
wiley   +1 more source

Oral Cancer and Hepatitis C Virus (HCV): Can HCV Alone Cause Oral Cancer? A Case Report.

open access: bronze, 1996
Yumiko Nagao   +4 more
openalex   +2 more sources

Switching From Standard to Extended Half‐Life Coagulation Factor Replacement in Haemophilia: Clinical Outcomes and Costs of Care in Finland

open access: yesHaemophilia, EarlyView.
ABSTRACT Introduction Real‐world data are needed to evaluate treatment implementation, outcomes and costs of care in haemophilia patients switching prophylaxis from standard half‐life (SHL) to extended half‐life (EHL) clotting factor concentrates (CFCs).
Mirkka Koivusalo   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy